{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:52:51Z","timestamp":1787503971843,"version":"build-2736575974"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010099","name":"Institute of Organic Chemistry and Biochemistry Czech Academy of Sciences","doi-asserted-by":"publisher","award":["RVO 61388963"],"award-info":[{"award-number":["RVO 61388963"]}],"id":[{"id":"10.13039\/501100010099","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ejmech.2025.118364","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T07:33:37Z","timestamp":1763537617000},"page":"118364","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"P3","title":["The 2-aminopyrimidine ring as a new scaffold for potent MRP1 inhibitors"],"prefix":"10.1016","volume":"302","author":[{"given":"Marijo","family":"\u010ci\u010dak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaroslav","family":"Koz\u00e1k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miroslav","family":"H\u00e1jek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavel","family":"Kraina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktor","family":"Kolman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Al\u017ebeta","family":"Magdolenov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jitka","family":"Viktorov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Mertl\u00edkov\u00e1-Kaiserov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4654-679X","authenticated-orcid":false,"given":"Zlatko","family":"Janeba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.118364_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2019.100645","article-title":"The multi-factorial nature of clinical multidrug resistance in cancer","volume":"46","author":"Assaraf","year":"2019","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.ejmech.2025.118364_bib2","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/med.21510","article-title":"Small-molecule inhibitors of multidrug resistance-associated protein 1 and related processes: a historic approach and recent advances","volume":"39","author":"Stefan","year":"2019","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2025.118364_bib3","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1080\/17425255.2021.1876661","article-title":"ABCB1, ABCG2, ABCC1, ABCC2, and ABCC3 drug transporter polymorphisms and their impact on drug bioavailability: what is our current understanding?","volume":"17","author":"Bruckmueller","year":"2021","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.ejmech.2025.118364_bib4","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.nbd.2009.07.030","article-title":"Structure and function of the blood-brain barrier","volume":"37","author":"Abbott","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ejmech.2025.118364_bib5","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1042\/bse0500161","article-title":"The P-glycoprotein multidrug transporter","volume":"50","author":"Sharom","year":"2011","journal-title":"Essays Biochem."},{"key":"10.1016\/j.ejmech.2025.118364_bib6","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s11060-004-6152-7","article-title":"Expression of drug resistance proteins Pgp, MRP1, MRP3, MRP5 AND GST-\u03c0 in human glioma","volume":"74","author":"Calatozzolo","year":"2005","journal-title":"J. Neuro Oncol."},{"key":"10.1016\/j.ejmech.2025.118364_bib7","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1080\/17425247.2024.2306138","article-title":"Blood\u2013brain barrier transporters: a translational consideration for CNS delivery of neurotherapeutics","volume":"21","author":"Ronaldson","year":"2024","journal-title":"Expet Opin. Drug Deliv."},{"key":"10.1016\/j.ejmech.2025.118364_bib8","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1602\/neurorx.2.1.86","article-title":"Blood-brain barrier active efflux transporters: ATP-binding cassette gene family","volume":"2","author":"L\u00f6scher","year":"2005","journal-title":"NeuroRx"},{"key":"10.1016\/j.ejmech.2025.118364_bib9","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.febslet.2005.12.036","article-title":"Substrate recognition and transport by multidrug resistance protein 1 (ABCC1)","volume":"580","author":"Deeley","year":"2006","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ejmech.2025.118364_bib10","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1124\/mol.53.1.141","article-title":"Kinetics of anthracycline efflux from multidrug resistance protein-expressing cancer cells compared with P-Glycoprotein-Expressing cancer cells","volume":"53","author":"Marbeuf-Gueye","year":"1998","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.118364_bib11","author":"Honjo"},{"key":"10.1016\/j.ejmech.2025.118364_bib12","unstructured":"Z.P. Lin, D.R. Johnson, R.A. Finch, M.G. Belinsky, G.D. Kruh, A.C. Sartorelli, Comparative study of the importance of multidrug resistance-associated protein 1 and P-Glycoprotein to drug sensitivity in Immortalized Mouse Embryonic Fibroblasts 1, n.d. http:\/\/aacrjournals.org\/mct\/article-pdf\/1\/12\/1105\/1931971\/gd1202001105.pdf."},{"key":"10.1016\/j.ejmech.2025.118364_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2022.100905","article-title":"ABC transporters affects tumor immune microenvironment to regulate cancer immunotherapy and multidrug resistance","volume":"66","author":"Fan","year":"2023","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.ejmech.2025.118364_bib14","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1146\/annurev-pharmtox-011613-135959","article-title":"Targeting multidrug resistance protein 1 (MRP1, ABCC1): past, present, and future","volume":"54","author":"Cole","year":"2014","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.ejmech.2025.118364_bib15","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1002\/cbin.11532","article-title":"Cisplatin\u2010resistant osteosarcoma cell\u2010derived exosomes confer cisplatin resistance to recipient cells in an exosomal circ_103801\u2010dependent manner","volume":"45","author":"Pan","year":"2021","journal-title":"Cell Biol. Int."},{"key":"10.1016\/j.ejmech.2025.118364_bib16","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1097\/CAD.0000000000001289","article-title":"LncRNA SNHG11 enhances bevacizumab resistance in colorectal cancer by mediating miR-1207-5p\/ABCC1 axis","volume":"33","author":"Huang","year":"2022","journal-title":"Anti Cancer Drugs"},{"key":"10.1016\/j.ejmech.2025.118364_bib17","doi-asserted-by":"crossref","first-page":"6573","DOI":"10.1158\/0008-5472.CAN-09-1075","article-title":"Small-molecule multidrug resistance-associated protein 1 inhibitor reversan increases the therapeutic index of chemotherapy in mouse models of neuroblastoma","volume":"69","author":"Burkhart","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2025.118364_bib18","unstructured":"S. Wang, H. Ryder, I. Pretswell, P. Depledge, J. Milton, T.C. Hancox, I. Dale, W. Dangerfield, P. Charlton, R. Faint, R. Dodd, S. Hassan, Studies on Quinazolinones as Dual Inhibitors of Pgp and MRP1 in Multidrug Resistance, n.d.."},{"key":"10.1016\/j.ejmech.2025.118364_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2021.100795","article-title":"Targeting multidrug resistance-associated protein 1 (MRP1)-expressing cancers: beyond pharmacological inhibition","volume":"59","author":"Hanssen","year":"2021","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.ejmech.2025.118364_bib20","doi-asserted-by":"crossref","first-page":"793","DOI":"10.2174\/138161282005140214165212","article-title":"ABC transporters in multidrug resistance and pharmacokinetics, and strategies for drug development","volume":"20","author":"Choi","year":"2014","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ejmech.2025.118364_bib21","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1023\/A:1026528926482","article-title":"Expression of multidrug Resistance-associated protein (MRP) in human gliomas","volume":"49","author":"Mohri","year":"2000","journal-title":"J. Neuro Oncol."},{"key":"10.1016\/j.ejmech.2025.118364_bib22","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3390\/antiox8080303","article-title":"Antioxidant, anti-inflammatory, and multidrug resistance modulation activity of silychristin derivatives","volume":"8","author":"Viktorov\u00e1","year":"2019","journal-title":"Antioxidants"},{"key":"10.1016\/j.ejmech.2025.118364_bib23","author":"Glavinas"},{"key":"10.1016\/j.ejmech.2025.118364_bib24","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.ejmech.2018.07.010","article-title":"Influence of the C-5 substitution in polysubstituted pyrimidines on inhibition of prostaglandin E2 production","volume":"156","author":"Kolman","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118364_bib25","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1021\/acs.oprd.0c00324","article-title":"Development of scalable synthesis of 5-Butyl-4-(4-methoxyphenyl)-6-phenylpyrimidin-2-amine (WQE-134), a dual inhibitor of nitric oxide and prostaglandin E 2 production","volume":"24","author":"Dosoudil","year":"2020","journal-title":"Org. Process Res. Dev."},{"key":"10.1016\/j.ejmech.2025.118364_bib26","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1002\/cmdc.202000258","article-title":"Polysubstituted pyrimidines as mPGES\u20101 inhibitors: discovery of potent inhibitors of PGE 2 production with strong anti\u2010inflammatory effects in carrageenan\u2010induced Rat Paw edema","volume":"15","author":"Kal\u010dic","year":"2020","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2025.118364_bib27","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.1002\/cmdc.202100263","article-title":"Polysubstituted pyrimidines as potent inhibitors of prostaglandin E 2 production: increasing aqueous solubility","volume":"16","author":"Kal\u010dic","year":"2021","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2025.118364_bib28","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3109\/03602532.2014.901348","article-title":"Importance of ABCC1 for cancer therapy and prognosis","volume":"46","author":"Kunick\u00e1","year":"2014","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.ejmech.2025.118364_bib29","doi-asserted-by":"crossref","first-page":"W739","DOI":"10.1093\/nar\/gkac382","article-title":"SynergyFinder 3.0: an interactive analysis and consensus interpretation of multi-drug synergies across multiple samples","volume":"50","author":"Ianevski","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2025.118364_bib30","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2174\/0929867013373903","article-title":"Reversal of multidrug resistance by the P-Glycoprotein modulator, LY335979, from the bench to the clinic","volume":"8","author":"Dantzig","year":"2001","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118364_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0291981","article-title":"Synergistic combination of doxorubicin with hydralazine, and disulfiram against MCF-7 breast cancer cell line","volume":"18","author":"Lafi","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2025.118364_bib32","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.3390\/ijms26041429","article-title":"Combining sulfonylureas with anticancer drugs: evidence of synergistic efficacy with doxorubicin in vitro and in vivo","volume":"26","author":"Tomczyk","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2025.118364_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116761","article-title":"Discovery of novel pyrazolo[1,5-a]pyrimidine derivatives as potent reversal agents against ABCB1-mediated multidrug resistance","volume":"277","author":"Fu","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118364_bib34","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.cell.2017.12.005","article-title":"ATP binding enables substrate release from multidrug resistance protein 1","volume":"172","author":"Johnson","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2025.118364_bib35","article-title":"Characterization of the kinetic cycle of an ABC transporter by single-molecule and cryo-EM analyses","volume":"9","author":"Wang","year":"2020","journal-title":"eLife"},{"key":"10.1016\/j.ejmech.2025.118364_bib36","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1021\/acscentsci.8b00369","article-title":"Molecular mechanism of ATP hydrolysis in an ABC transporter","volume":"4","author":"Prie\u00df","year":"2018","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.ejmech.2025.118364_bib37","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1074\/jbc.M310711200","article-title":"Molecular modeling correctly predicts the functional importance of Phe594 in transmembrane helix 11 of the multidrug resistance protein, MRP1 (ABCC1)","volume":"279","author":"Campbell","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2025.118364_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2025.152074","article-title":"Tetrahydroquinoline\/4,5-dihydroisoxazoline hybrids counteracts multidrug resistance by inhibiting MRP1-mediated drug efflux","volume":"774","author":"da Silva Pereira","year":"2025","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejmech.2025.118364_bib39","doi-asserted-by":"crossref","first-page":"3854","DOI":"10.1111\/febs.16374","article-title":"GSH facilitates the binding and inhibitory activity of novel multidrug resistance protein 1 (MRP1) modulators","volume":"289","author":"Hanssen","year":"2022","journal-title":"FEBS J."},{"key":"10.1016\/j.ejmech.2025.118364_bib40","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1124\/dmd.109.026633","article-title":"Molecular basis for reduced estrone sulfate transport and altered modulator sensitivity of transmembrane helix (TM) 6 and TM17 mutants of multidrug resistance protein 1 (ABCC1)","volume":"37","author":"Maeno","year":"2009","journal-title":"Drug Metabol. Dispos."},{"key":"10.1016\/j.ejmech.2025.118364_bib41","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1124\/jpet.102.044073","article-title":"Structural requirements for functional interaction of glutathione tripeptide analogs with the human multidrug resistance protein 1 (MRP1)","volume":"304","author":"Leslie","year":"2003","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejmech.2025.118364_bib42","doi-asserted-by":"crossref","first-page":"13906","DOI":"10.1074\/jbc.M600869200","article-title":"Role of GSH in estrone sulfate binding and translocation by the multidrug resistance protein 1 (MRP1\/ABCC1)","volume":"281","author":"Rothnie","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2025.118364_bib43","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.niox.2017.05.001","article-title":"Polysubstituted 4,6-bis(hetero)arylpyrimidines as dual inhibitors of nitric oxide and prostaglandin E2 production","volume":"67","author":"Kolman","year":"2017","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.ejmech.2025.118364_bib44","series-title":"(12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (43","author":"Jans A","year":"2012"},{"key":"10.1016\/j.ejmech.2025.118364_bib45","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.csbj.2015.09.001","article-title":"Searching for drug synergy in complex dose\u2013response landscapes using an interaction potency model","volume":"13","author":"Yadav","year":"2015","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.ejmech.2025.118364_bib46","unstructured":"Chemical Computing Group ULC. Molecular Operating Environment (MOE). 1010 Sherbooke St. West, Suite #910, Montreal, QC, Canada, H3A 2R7, 2023, (n.d.)."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425011298?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425011298?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T07:02:59Z","timestamp":1773817379000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425011298"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":46,"alternative-id":["S0223523425011298"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118364","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The 2-aminopyrimidine ring as a new scaffold for potent MRP1 inhibitors","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118364","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118364"}}